Published in Gene Therapy Weekly, March 30th, 1998
R. Martiniello, representing colleagues from several centers in Australia, noted that advanced prostate cancer is invariably lethal once it becomes hormone refractory. At the 89th Annual Meeting of the American Association for Cancer Research, held March 28 - April 1, 1998, in New Orleans, Louisiana, Martiniello et al. presented results from their efforts to incorporate EPT in the arsenal against androgen-independent prostate cancer (abstract "Gene Therapy for Prostate Cancer: Comparison of Two Different Enzyme...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly